Consolidated Balance Sheet

Consolidated balance sheet

€ million

 

Note

 

Dec. 31, 2025

 

Dec. 31, 20241

Non-current assets

 

 

 

 

 

 

Goodwill

 

18

 

17,934

 

19,107

Other intangible assets

 

19

 

7,662

 

6,351

Property, plant and equipment

 

20

 

9,940

 

10,025

Investments accounted for using the equity method

 

 

 

3

 

3

Non-current receivables

 

25

 

32

 

27

Other non-current financial assets

 

36

 

992

 

1,172

Other non-current non-financial assets

 

22

 

114

 

134

Non-current income tax receivables

 

15

 

3

 

9

Deferred tax assets

 

15

 

1,618

 

1,318

 

 

 

 

38,298

 

38,146

Current assets

 

 

 

 

 

 

Inventories

 

24

 

4,562

 

4,484

Trade and other current receivables

 

25

 

3,947

 

3,947

Contract assets

 

26

 

103

 

132

Other current financial assets

 

36

 

688

 

642

Other current non-financial assets

 

22

 

716

 

621

Current income tax receivables

 

15

 

356

 

512

Cash and cash equivalents

 

35

 

2,740

 

2,517

Assets held for sale

 

6

 

118

 

597

 

 

 

 

13,230

 

13,450

Total assets

 

 

 

51,527

 

51,596

 

 

 

 

 

 

 

Total equity

 

34

 

 

 

 

Equity capital

 

 

 

565

 

565

Capital reserves

 

 

 

3,814

 

3,814

Retained earnings

 

 

 

24,039

 

22,087

Gains/losses recognized in equity

 

 

 

174

 

3,448

Equity attributable to shareholders of Merck KGaA, Darmstadt, Germany

 

 

 

28,592

 

29,914

Non-controlling interests

 

 

 

68

 

75

 

 

 

 

28,660

 

29,989

Non-current liabilities

 

 

 

 

 

 

Non-current provisions for employee benefits

 

33

 

1,553

 

1,956

Other non-current provisions

 

27

 

259

 

257

Non-current financial debt

 

37

 

10,730

 

6,997

Other non-current financial liabilities

 

38

 

104

 

144

Other non-current non-financial liabilities

 

29

 

9

 

12

Non-current income tax liabilities

 

15

 

36

 

36

Deferred tax liabilities

 

15

 

1,134

 

909

 

 

 

 

13,826

 

10,312

Current liabilities

 

 

 

 

 

 

Current provisions for employee benefits

 

33

 

63

 

66

Current provisions

 

27

 

481

 

505

Current financial debt

 

37

 

1,238

 

3,304

Other current financial liabilities

 

38

 

998

 

1,031

Trade and other current payables

 

30

 

2,110

 

2,275

Refund liabilities

 

9

 

985

 

869

Current income tax liabilities

 

15

 

1,579

 

1,527

Other current non-financial liabilities

 

29

 

1,588

 

1,562

Liabilities directly related to assets held for sale

 

6

 

 

157

 

 

 

 

9,042

 

11,295

Total equity and liabilities

 

 

 

51,527

 

51,596

1

Previous-year figures have been adjusted owing to the finalization of the purchase price allocation in connection with the acquisitions of Mirus Bio LLC, USA, Unity-SC SAS, France, as well as Hub Organoids Holding B.V., Netherlands (see Note (6) Acquisitions and divestments).

Share this page: